Elise represents emerging companies, public companies and VC funds. She advises clients on matters including formation, VC financings, and Securities and Exchange Commission reporting obligations.
MapLight Therapeutics Closes Oversubscribed $372.5 Million Series D
July 28, 2025
Cooley advised MapLight Therapeutics, a clinical-stage biopharmaceutical company developing targeted, novel therapies for patients with central nervous system disorders, on its oversubscribed $372.5 million Series D financing.